R47.0
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age >18 2. Informed consent 3. Diagnosed with aphasia (post-acute phase: 2-12 months post stroke/trauma or chronic phase: >12 months post stroke/trauma) 4. Situative appropriate speech perception (AAT subtest speech perception: PR > 10 or positive appraisal of speech and language therapist 5. Inward patients (specialised ward for aphasia, University Clinics Aachen)
Exclusion criteria
Exclusion criteria: 1. Non-compensability of visual impairments (e.g. neglect, hemianopsia) in the central visual field 2. Motoric or sensoric impariments on the left side of the body (in left-hemispheric stroke) 3. Psychotic, obsessive-compulsory or hypochondric disorder 4. Restrictive impairments of auditory processing; high auditive sensitivity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Physiological distress: heart rate variability, measured by lead of heart rate during independent variables (progressive muscle relaxation, cognitive distress, physiological distress [noise]) and dependent variables (speech production, speech perception) 2. Subjective distress: measured by changes in valence and arousal ratings (nonverbal SAM-scales) before and after IVs and DVs Measurements in Phase 1: (a) on 1 point of time (b)on three consecutive time points (cross-sectional design). Measurements in Phase 2: on three consecutive time points at the beginning and the end of the in-ward therapy, questionnaires before und after Measurements in Phase 3: on three consecutive time points before after and in between group therapies (3 times 3 measurements, 6 weeks, longitudinal design) 3. Chronic distress and related parameters: questionnaires - Depression and anxiety: Hospital Anxiety Depression Scale (HADS), Beck’s Depressionsinventory (BDI-II) - Quality of life: the Aachen inventory of quality of life (ALQI) - Distress: Stress coping inventory (SCI), Perceived Stress Questionnaire (PSQ-20), modified Perceived Stress Scale (mPSS) Measurements in Phase 1: on the first (three) consecutive time points. Measurements in Phase 2: in the first session of each measurement block: before at the beginning and the end of the in-ward therapy, questionnaires before and after the in-ward therapy. Measurements in Phase 3: in the first session of each measurement block: before after and in between group therapies | — |
Secondary
| Measure | Time frame |
|---|---|
| Speech processes in 1. Speech production (analysis of spontaneous speech, linguistic parameters) and 2. Speech perception (analysis of auditive speech perception) Measurements in Phase 1: on three consecutive time points (cross-sectional design). Measurements in Phase 2: on three consecutive time points before after and in between group therapies (3 times 3 measurements, 7 weeks, longitudinal design) | — |
Countries
Germany
Contacts
Uniklinik RWTH Aachen, Klinik für Neurologie